Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.

Weiselberg, L

Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary. [electronic resource] - Cancer treatment reports Aug 1982 - 1675-6 p. digital

Publication Type: Journal Article

0361-5960


Adult
Aged
Antineoplastic Agents--adverse effects
Carcinoma, Squamous Cell--drug therapy
Drug Evaluation
Female
Germanium--adverse effects
Humans
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Organometallic Compounds
Ovarian Neoplasms--drug therapy
Spiro Compounds--adverse effects